Reports
Reports
Sale
The Asia Pacific bone cement market was valued at USD 219.95 million in 2023, driven by the increasing number of orthopedic surgeries and rising innovations in bone cement formulations in the region. The market is expected to grow at a CAGR of 6.60% during the forecast period of 2024-2032, with the values likely to reach USD 390.36 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Bone cement is a type of biomaterial that is used within human bodies to repair fractures, support joint arthroplasty, and fill in gaps between implant prosthesis and the bone. Bone cement is rigid and provides additional stability. It is a fine powder which is mixed with a liquid to create a paste. Bone cement can also provide additional strength to artificial implants.
The Asia Pacific bone cement market value is benefitting from the rising advancements in bone cement formulations and delivery methods that improve the performance and safety of these products. The market growth is also supported by the heightened awareness of bone health among the public and the increasing innovations in diagnostic technologies. Such developments are leading to early diagnosis and treatment of bone disorders, which also affects the demand in the global bone cement market. Other factors that influence the market dynamics include rising healthcare expenditure, supportive government policies, and the growing research initiatives focused on enhancing orthopedic treatments.
Growing Aging Population to Affect the Market Landscape Significantly
According to the United Nations Economic and Social Commission for Asia and the Pacific, around 697 million older adults (aged 60 or above) were living in the Asia and Pacific in 2023, accounting for 60% of all older adults worldwide. Further, it is estimated that 1 in 7 individuals in the region are currently aged 60 years or over, and by 2050, 1 out of 4 people will fall in this age cohort. This rapid demographic shift is a significant growth driver of the market as older people are at a higher risk of developing bone-related conditions such as osteoporosis and osteoarthritis. These conditions often lead to weakened joints and bone which prompts the need for surgical interventions requiring bone cement. Moreover, a higher rate of bone injuries and fractures among the elderly population is poised to propel the market growth in the forecast period.
Increased Demand for Antibiotic-Loaded Bone Cement to Elevate Asia Pacific Bone Cement Market Value
There is a growing market demand for bone cement incorporated with antibiotics in the Asia Pacific region, owing to its advantages in preventing post-surgical infections, particularly in the case of orthopedic surgeries. Antibiotic-loaded bone cement mitigates the risk of complications in joint replacement surgeries by offering a high local dose of antibiotics. For example, the leading provider of bone cement Heraeus Medical GmbH has introduced COPAL® G+C, a high-viscosity and radiopaque bone cement, carrying an antibiotic combination of 1 g clindamycin and 1 g gentamicin. The rising availability of such advanced bone cement products is expected to improve clinical outcomes and support market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Key Trends | Impact |
Innovations in Bone Cement Delivery Systems | The rising advancements in bone cement delivery systems are resulting in the accurate application of bone cement during surgeries, leading to precise bone cement delivery and better patient outcomes. Moreover, the increasing focus on improving the safety features of bone cement delivery systems is anticipated to augment the market demand. |
Rising Preference for Minimally Invasive Procedures | There is a rising patient inclination towards minimally invasive surgical procedures, such as vertebroplasty, kyphoplasty, and minimally invasive joint replacements, due to the associated advantages like shorter recovery time and lower risk of complications. These surgical interventions often require bone cement for fixing implants in place and thus their growing demand is poised to boost the Asia Pacific bone cement market share. |
Improved Healthcare Access and Infrastructure | In the Asia Pacific region, increased investment in healthcare infrastructure is a major market trend that is influencing the adoption of advanced orthopedic procedures and bone cement products. Moreover, the expansion of specialized orthopedic centers further fuels the market growth. |
Growing Demand for Biodegradable Bone Cements | The market is witnessing a growing demand for biodegradable bone cement due to its ability to resorb and integrate with natural bone tissue. Biodegradable bone cements are known to promote bone regeneration and healing, leading to better clinical outcomes and reduced risk of long-term complications. |
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Market Breakup by Country
Polymethyl Methacrylate (PMMA) Cement Segment is Anticipated to Witness Substantial Market Growth
Based on product, the market report offers an insight into calcium phosphate cement (CPC), glass polyalkenoate cement and polymethyl methacrylate (PMMA) cement. The polymethyl methacrylate segment holds a significant share in the Asia Pacific region. Polymethyl methacrylate bone cement is gaining traction in present-day orthopedic surgeries due to the high endurance of this product and its compatibility with modern surgical techniques. Over the forecast period, the anticipated increase in the application of the product in percutaneous vertebroplasty and kyphoplasty is poised to propel the Asia Pacific bone cement market demand in healthcare units. Moreover, polymethyl methacrylate exhibits an elastic effect which is a critical relative advantage of the product, accelerating the growth of the Asia Pacific market for bone cement.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the region, the market is segmented into China, Japan, India, South Korea, and Australia. China covers a significant share of the market due to a rapidly aging population, growing demand for minimally invasive procedures in orthopedic surgeries, and increasing healthcare expenditure. The market growth is also supported by the expansion of hospitals and clinics and increased focus on improving access to orthopedic care, particularly in rural areas. India also holds a substantial market value, owing to the rising incidences of orthopedic disorders caused by sedentary lifestyles, sports injuries, and the increasing aging population.
The key features of the market report comprise the patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Johnson & Johnson MedTech (Depuy Synthes)
Depuy Synthes is the orthopedics division of Johnson & Johnson. It is a medical device manufacturing company that was founded in the year 1895 and was later acquired by Johnson and Johnson. The company provides data-enabled orthopedic and MedTech solutions. Major bone cement products developed by this company facilitate hip and knee replacement.
Stryker Corporation
Stryker Corporation is a multinational MedTech company that was founded in the year 1941 with headquarters in Michigan, United States. The company aims to develop innovative orthopedic, medical, surgical, and neurotechnological products to cater to the demand of patients suffering from chronic musculoskeletal disorders. Stryker operates across more than 75 countries and has a workforce of more than 46,000. One of its key products is SpinePlex bone cement which is clinically proven to possess high compressive and flexural strengths. Stryker is known to heavily invest in advancing bone cement formulations and contributes significantly to the Asia Pacific bone cement market growth.
Zimmer Biomet Holdings, Inc
Zimmer Biomet Holdings, Inc. is a leading medical technology company that was founded in the year 1927 and has been helping consumers improve mobility by innovating various MedTech products. This company designs, manufactures, and innovates orthopedic solutions including bone cement products. It operates across 25 countries and is expanding its product offerings to around 100 countries.
Smith & Nephew plc
Smith & Nephew plc, also known as Smith+Nephew, is a global medical equipment manufacturing company with a prominent presence in the market. The company offers a range of bone cement products such as its RALLY™ Bone Cement portfolio and leverages strategic partnerships to expand market reach.
Other key players in the market include Medtronic plc, DJO, LLC, Globus Medical, Inc., Arthrex, Inc., Cardinal Health, Inc., and Heraeus Medical LLC.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Bone Cement Market Overview
3.1 Global Bone Cement Market
3.1.1 Global Bone Cement Market Historical Value (2017-2023)
3.1.2 Global Bone Cement Market Forecast Value (2024-2032)
3.2 Asia Pacific Bone Cement Market
3.2.1 Asia Pacific Bone Cement Market Historical Value (2017-2023)
3.2.2 Asia Pacific Bone Cement Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Asia Pacific Bone Cement Market Landscape*
5.1 Asia Pacific Bone Cement: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Country
5.2 Asia Pacific Bone Cement: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Application
6 Asia Pacific Bone Cement Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Asia Pacific Bone Cement Market Segmentation (2017-2032)
7.1 Asia Pacific Bone Cement Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Calcium Phosphate Cement (CPC)
7.1.3 Glass Polyalkenoate Cement
7.1.4 Polymethyl Methacrylate (PMMA) Cement
7.2 Asia Pacific Bone Cement Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Kyphoplasty
7.2.3 Arthroplasty
7.2.4 Vertebroplasty
7.3 Asia Pacific Bone Cement Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospital
7.3.3 Ambulatory Surgical Centres
7.3.4 Clinics
7.4 Asia Pacific Bone Cement Market (2017-2032) by Country
7.4.1 Market Overview
7.4.2 China
7.4.3 Japan
7.4.4 India
7.4.5 South Korea
7.4.6 Australia
8 China Bone Cement Market Segmentation (2017-2032)
8.1 China Bone Cement Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Calcium Phosphate Cement (CPC)
8.1.3 Glass Polyalkenoate Cement
8.1.4 Polymethyl Methacrylate (PMMA) Cement
8.2 China Bone Cement Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Kyphoplasty
8.2.3 Arthroplasty
8.2.4 Vertebroplasty
8.3 China Bone Cement Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospital
8.3.3 Ambulatory Surgical Centres
8.3.4 Clinics
9 Japan Bone Cement Market Segmentation (2017-2032)
9.1 Japan Bone Cement Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Calcium Phosphate Cement (CPC)
9.1.3 Glass Polyalkenoate Cement
9.1.4 Polymethyl Methacrylate (PMMA) Cement
9.2 Japan Bone Cement Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Kyphoplasty
9.2.3 Arthroplasty
9.2.4 Vertebroplasty
9.3 Japan Bone Cement Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospital
9.3.3 Ambulatory Surgical Centres
9.3.4 Clinics
10 India Bone Cement Market Segmentation (2017-2032)
10.1 India Bone Cement Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Calcium Phosphate Cement (CPC)
10.1.3 Glass Polyalkenoate Cement
10.1.4 Polymethyl Methacrylate (PMMA) Cement
10.2 India Bone Cement Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Kyphoplasty
10.2.3 Arthroplasty
10.2.4 Vertebroplasty
10.3 India Bone Cement Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospital
10.3.3 Ambulatory Surgical Centres
10.3.4 Clinics
11 South Korea Bone Cement Market Segmentation (2017-2032)
11.1 South Korea Bone Cement Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Calcium Phosphate Cement (CPC)
11.1.3 Glass Polyalkenoate Cement
11.1.4 Polymethyl Methacrylate (PMMA) Cement
11.2 South Korea Bone Cement Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Kyphoplasty
11.2.3 Arthroplasty
11.2.4 Vertebroplasty
11.3 South Korea Bone Cement Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospital
11.3.3 Ambulatory Surgical Centres
11.3.4 Clinics
12 Australia Bone Cement Market Segmentation (2017-2032)
12.1 Australia Bone Cement Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Calcium Phosphate Cement (CPC)
12.1.3 Glass Polyalkenoate Cement
12.1.4 Polymethyl Methacrylate (PMMA) Cement
12.2 Australia Bone Cement Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Kyphoplasty
12.2.3 Arthroplasty
12.2.4 Vertebroplasty
12.3 Australia Bone Cement Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospital
12.3.3 Ambulatory Surgical Centres
12.3.4 Clinics
13 Regulatory Framework
13.1 Regulatory Overview
13.2 Asia-Canada-Singapore-Switzerland (ACSS) Consortium
13.3 Central Drugs Standard Control Organisation (CDSCO)
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Asia Pacific
17.2 Johnson & Johnson Services, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Stryker Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Zimmer Biomet Holdings, Inc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Smith & Nephew plc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic plc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 DJO, LLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Globus Medical, Inc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Arthrex, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Cardinal Health, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Heraeus Medical LLC
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Asia Pacific Bone Cement Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.